PATENT CLAIM ANALYSIS

Application Number: 16070667
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["536", "018100"]

Abstract:
The present invention relates to dicaffeoyl spermidine cyclized derivatives and a preparation method and use thereof. Biological activity experiments show that the dicaffeoyl spermidine cyclized derivatives of the present invention have anti-Senile dementia activity and antioxidant activity, and their activity are even better than that of a positive control drug, thus suitable for the prevention and treatment of neurodegenerative diseases such as Senile dementia.

Claim (Index 11):
A method for preventing and treating a neurodegenerative disease, which comprises administering to a subject in need of treatment a therapeutically effective amount of the dicaffeoyl spermidine cyclized derivatives or the pharmaceutically acceptable salts thereof according to  claim 1 .

Metadata:
- Claim Count in Document: 23.0
- Percentile: 95.0
- Lexical Diversity: 1.47826
- Patent Class: 536.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15170871', '13934355', '13934277', '15527280', '13542687']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.62827460029282
- 35 USC 102 Novelty (BERT): 0.4920151935523425
- Combined Prediction Score: 0.6146486596187724
- Mean Citation Score: 196.039112
- Max Citation Score: 233.38445
- Similarity Product: 169.91640977843403

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test